Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1993-10-12
1996-12-17
Campell, Bruce R.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 235, 935 34, C07H 2104
Patent
active
055854796
ABSTRACT:
The present invention provides a method for the treatment of septic shock d inflammatory complications of shock. A process for selectively inhibiting the expression of the human ELAM-I mRNA transcript using at least one oligonucleotide which is substantially complementary to at least a portion of the ELAM-I gene is disclosed, as are composition comprising the oligonucleotide.
REFERENCES:
patent: 5272263 (1993-12-01), Hession et al.
E Uhlmann et al (1990) Chemical Reviews 90:544-584.
T Collins et al (1991) J Biol Chem 266:2466-2473.
C P Leamon et al (1991) Proc Natl Acad Sci USA 88:5572-5576.
P L Felgner et al (1987) Proc Natl Acad Sci USA 84:7413-7417.
S Kawai et al (1984) Mol Cell Biol 4:1172-1174.
R Weiss (1991) Science News 139: 108-109.
C A Stein et al (1993) Science 261: 1004-1012.
R W Wagner (1994) Nature 372: 333-335.
S Wu-Pong (1994) Pharmaceutical Technology 118: 102-114.
N Miller et al (1994) Parasitology Today 10: 92-97.
R A Stull et al (1995) Pharmaceutical Research 12: 465-483.
Bradley Matthews O.
Hoke Glenn D.
Lee Che-Hung
Williams Taffy J.
Campell Bruce R.
Garvert, Esq. William
Spevack, Esq. A. D.
The United States of America as represented by the Secretary of
LandOfFree
Antisense oligonucleotides directed against human ELAM-I RNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides directed against human ELAM-I RNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides directed against human ELAM-I RNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1992246